LivaNova PLC is 1.9x more valuable than Axogen, Inc. by market capitalization ($4.36 B vs $2.24 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LIVN | AXGN |
|---|---|---|
| Market cap | $4.36 B | $2.24 B |
| US-listed rank | #1509 | #2030 |
| Revenue (latest FY) | $1.39B | $225.21M |
| Net income (latest FY) | -$242.50M | -$15.70M |
| Net margin | -17.5% | -7.0% |
| SEC filings | 917 | 1,334 |
LivaNova PLC is 1.9x more valuable than Axogen, Inc. by market capitalization ($4.36 B vs $2.24 B).
In their latest fiscal years, LivaNova PLC reported $1.39B in revenue while Axogen, Inc. reported $225.21M.
Full pages: LivaNova PLC and Axogen, Inc., or browse the full rankings.